AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Fri, 24 May 2024

Trading levels for OCGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.90 10.47 %
R2 1.84 7.02 %
R1 1.80 4.90 %
Current price: 1.72
Support S1 1.69 -1.99 %
S2 1.65 -4.12 %
S3 1.59 -7.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.88 9.30 %
R2 1.83 6.40 %
R1 1.73 0.581 %
Current price 1.72
Support S1 1.64 -4.65%
S2 1.34 -22.09%
S3 1.32 -23.26%

OCGN Predictions History

2 years ago
JS predicted that OCGN for 2021-05-24 is going $8.33 (4.65%)

3 years ago
Milan predicted that OCGN for 2021-05-24 is going $7.13 (-17.67%)

Rank:

3 years ago
JS predicted that OCGN for 2021-05-17 is going $9.24 (7.44%)

3 years ago
xstreemen.238124 predicted that OCGN for 2021-05-17 is going $8.75 (1.74%)

Rank:

3 years ago
dhamm4980.238872 predicted that OCGN for 2021-05-17 is going

Rank:

3 years ago
saitochloe.235824 predicted that OCGN for 2021-05-17 is going

Rank:

3 years ago
girmamekuria predicted that OCGN for 2021-05-17 is going

Rank:

3 years ago
Cassandra Burke predicted that OCGN for 2021-05-17 is going $14.00 (60.00%)

Rank:

3 years ago
JS predicted that OCGN for 2021-05-11 is going $10.48 (5.86%)

3 years ago
veronicaxmatheny.237921 predicted that OCGN for 2021-05-11 is going $13.00 (31.31%)

Rank:
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT